BACKGROUND: Although sensitization to fungal allergens is prevalent in inner-city children with asthma, the relationship between fungal exposure and morbidity is poorly understood. OBJECTIVE: We examined relationships between fungal sensitization, exposure, and asthma morbidity in inner-city children. METHODS: Participants were 5 to 11 years old and enrolled in the Inner-City Asthma Study. This report includes the subset of children with at least 1 positive skin test (PST) response to a fungal allergen extract; for these children, indoor and outdoor airborne culturable fungi levels were measured at baseline and throughout the 2-year study. Asthma morbidity measures were collected prospectively. The primary outcome was symptom days per 2 weeks. RESULTS: At baseline, children with a PST response to a fungal allergen extract had significantly more symptom days compared with those without a PST response to any fungal allergen extract (6.3 vs 5.7 days per 2 weeks, P = .04). During the study, increases in total fungal exposure and indoor Penicillium species exposure were associated with increases in symptom days and asthma-related unscheduled visits. Indoor exposures to total fungi and to Penicillium species were associated with significant increases in unscheduled visits, even after controlling for outdoor fungal levels. Adverse effects associated with exposure to a specific fungus were stronger among children with PST responses to that fungal allergen extract compared with those seen in children with negative skin test responses. CONCLUSION: Outdoor fungal exposure is primarily associated with increased asthma symptoms and increased risk of exacerbations in this population.
BACKGROUND: Although sensitization to fungal allergens is prevalent in inner-city children with asthma, the relationship between fungal exposure and morbidity is poorly understood. OBJECTIVE: We examined relationships between fungal sensitization, exposure, and asthma morbidity in inner-city children. METHODS:Participants were 5 to 11 years old and enrolled in the Inner-City Asthma Study. This report includes the subset of children with at least 1 positive skin test (PST) response to a fungal allergen extract; for these children, indoor and outdoor airborne culturable fungi levels were measured at baseline and throughout the 2-year study. Asthma morbidity measures were collected prospectively. The primary outcome was symptom days per 2 weeks. RESULTS: At baseline, children with a PST response to a fungal allergen extract had significantly more symptom days compared with those without a PST response to any fungal allergen extract (6.3 vs 5.7 days per 2 weeks, P = .04). During the study, increases in total fungal exposure and indoor Penicillium species exposure were associated with increases in symptom days and asthma-related unscheduled visits. Indoor exposures to total fungi and to Penicillium species were associated with significant increases in unscheduled visits, even after controlling for outdoor fungal levels. Adverse effects associated with exposure to a specific fungus were stronger among children with PST responses to that fungal allergen extract compared with those seen in children with negative skin test responses. CONCLUSION: Outdoor fungal exposure is primarily associated with increased asthma symptoms and increased risk of exacerbations in this population.
Authors: R J Delfino; B D Coate; R S Zeiger; J M Seltzer; D H Street; P Koutrakis Journal: Am J Respir Crit Care Med Date: 1996-09 Impact factor: 21.405
Authors: R A Wood; P A Eggleston; P Lind; L Ingemann; B Schwartz; S Graveson; D Terry; B Wheeler; N F Adkinson Journal: Am Rev Respir Dis Date: 1988-02
Authors: R Evans; P J Gergen; H Mitchell; M Kattan; C Kercsmar; E Crain; J Anderson; P Eggleston; F J Malveaux; H J Wedner Journal: J Pediatr Date: 1999-09 Impact factor: 4.406
Authors: Kathleen Belanger; William Beckett; Elizabeth Triche; Michael B Bracken; Theodore Holford; Ping Ren; Jean-ellen McSharry; Diane R Gold; Thomas A E Platts-Mills; Brian P Leaderer Journal: Am J Epidemiol Date: 2003-08-01 Impact factor: 4.897
Authors: Ellen F Crain; Michelle Walter; George T O'Connor; Herman Mitchell; Rebecca S Gruchalla; Meyer Kattan; George S Malindzak; Paul Enright; Richard Evans; Wayne Morgan; James W Stout Journal: Environ Health Perspect Date: 2002-09 Impact factor: 9.031
Authors: B Behbod; J E Sordillo; E B Hoffman; S Datta; M L Muilenberg; J A Scott; G L Chew; T A E Platts-Mills; J Schwartz; H Burge; D R Gold Journal: Allergy Date: 2013-10-10 Impact factor: 13.146
Authors: Félix E Rivera-Mariani; Michel Almaguer; María Jesús Aira; Benjamín Bolaños-Rosero Journal: P R Health Sci J Date: 2020-09 Impact factor: 0.705